Misery perfusion with preserved vascular reactivity in Alzheimer's disease

Annals of the New York Academy of Sciences

Volumn 826, Issue , 1997, Pages 272-281

  Nagata, Ken ^a   Buchan, Robert J ^a   Yokoyama, Eriko ^a   Kondoh, Yasushi ^a   Sato, Mika ^a   Terashi, Hiroo ^a   Satoh, Yuichi ^a   Watahiki, Yasuhito ^a   Senova, Melis ^a   Hirata, Yutaka ^a   Hatazawa, Jun ^a  

^a RESEARCH INSTITUTE FOR BRAIN AND BLOOD VESSELS AKITA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; BLOOD VESSEL REACTIVITY; BRAIN BLOOD FLOW; BRAIN METABOLISM; BRAIN OXYGEN CONSUMPTION; BRAIN REGION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCAPNIA; HYPERVENTILATION; MALE; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY;

EID: 9844261700     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb48479.x     Document Type: Conference Paper

References (29)

1. MAYEUX, R. et al. 1985. Heterogeneity in dementia of Alzheimer's type: Evidence of subgroups. Neurology 35: 453-461.
2. GRUBB, R. et al. 1977. Cerebral blood flow, oxygen utilization and blood volume in dementia. Neurology 27: 905-910.
3. FRACKOWIAK, R. S. J. et al. 1981. Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain 104: 753-778.
4. FRIEDLAND, R. P. et al. 1985. Alzheimer's disease: Anterior-posterior and lateral hemispheric alterations in cortical glucose utilization. Neurosci. Lett. 53: 235-240.
5. 99mTc-HM-PAO in the investigation of dementia. J. Neurol. Neurosurg. Psychiatry 50: 1101-1109.
6. RAPOPORT, S. T. 1990. Positron emission tomography in Alzheimer's disease in relation to disease pathogenesis: A critical review. Cerebrovasc. Brain Metab. Rev. 3: 297-335.
7. SALMON, E. et al 1994. Differential diagnosis of Alzheimer's disease with PET. J. Nucl. Med. 35: 391-398.
8. FUKUYAMA, H. et al. 1994. Altered cerebral energy metabolism in Alzheimer's disease. A PET study. J. Nucl. Med. 35: 1-6.
9. MIELKE, R. et al. 1994. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: Comparison of perfusion and metabolic pattern. Eur. J. Nucl. Med. 21: 1052-1060.
10. HARDY, J. A. & G. A. HIGGINS. 1992. Alzheimer's disease: The amyloid cascade hypothesis. Science 256: 184-185.
11. MURRELL, J. et al. 1991. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254: 97-99.
12. SCHELLENBERG, G. D. et al. 1992. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 258: 668-671.
13. SAUNDERS, A. M. et al. 1993. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467-1472.
14. MULLAN, M. & F. CRAWFORD. 1993. Genetic and molecular advances in Alzheimer's disease. Trends Neurosci. 16: 398-403.
15. SHOJI, M. et al. 1990. The amyloid β-protein precursor is localized in smooth muscle cells of leptomeningeal vessels. Brain Res. 530: 113-116.
16. KAWAI, M. et al. 1993. Degeneration of amyloid precursor protein-containing smooth muscle cells in cerebral amyloid angiopathy. Brain Res. 623: 142-146.
17. TAGLIAVINI, F. et al. 1991. Coexistence of Alzheimer's amyloid precursor protein and amyloid protein in cerebral vessel walls. Lab. Invest. 62: 761-767.
18. YAMAGUCHI, H. et al. 1992. Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. Am. J. Pathol. 141: 249-259.
19. WISNIEWSKI, H. M. et al. 1991. Ultrastructural studies of the cell forming amyloid in the cortical vessel wall in Alzheimer's disease. Acta Neuropathol. 84: 117-127.
20. MCKHANN, G. et al. 1984. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 5: 2801-2808.
21. ROGERS, R. et al. 1986. Decreased cerebral blood flow precedes multi-infarct dementia but follows senile dementia of Alzheimer's type. Neurology 36: 1-6.
22. BARON, J. C. et al. 1984. Local interrelationship of cerebral oxygen consumption and glucose utilization in normal subjects and in ischemic stroke patients: A positron tomography study. J. Cereb. Blood Flow. Metab. 4: 140-149.
23. GIBBS, J. M. et al. 1984. Evaluation of cerebral perfusion reserve in patients with carotid-artery occlusion. Lancet: 182-186.
24. DE LA TORRE, J. C. & T. MUSSIVAND. 1993. Can disturbed brain microcirculation cause Alzheimer's disease? Neurol. Res. 15: 146-153.
25. KALARIA, R. N. et al. 1992. The blood-brain barrier and cerebral microcirculation in Alzheimer's disease. Cerebovasc. Brain Metab. Rev. 4: 226-260.
26. DE LA Torre, J. C. 1994. Impaired brain microcirculation may trigger Alzheimer's disease. Neurosci. Biobehav. Rev. 18(3): 397-401.
27. KONDOH, Y. et al. 1997. Dynamic FDG-PET study in probable Alzheimer's disease. Ann. N. Y. Acad. Sci. This volume.
28. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 28: 897-916.
29. JAGUST, W. J. et al. 1991. Diminished glucose transport in Alzheimer's disease: Dynamic PET studies. J. Cereb. Blood Flow. Metab. 11: 323-330.